[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 19, Issue 4 (winter 2021) ::
jmj 2021, 19(4): 13-18 Back to browse issues page
Seroloprevalence of Hepatits G Virus (HGV) in Hemodialysis Patients Jahrom-Iran, 1400
Masihollah Shakeri , Ardavan Mojmeli , Karamatollah Rahmanian , Fatemeh Sotoodeh jahromi , Aida Rahmanian , Abdolreza Sotoodeh jahromi *
Jahrom University of medical sciences, Jahrom, Iran
Abstract:   (869 Views)
OS:TX_1~ABS:AT/HTC:TX_2~ABS:AT/ATAO:ADD/AFF:AT
Introduction: Hemodialysis patients are at risk for viral hepatitis due to invasive procedures and frequent contact with blood and body fluids, this increases the importance of viral hepatitis in patients undergoing hemodialysis. The aim of this study was to determine the serological prevalence of hepatitis G virus (HGV) and its associated factors in hemodialysis patients in Jahrom-Iran.
Material and Methods: This cross-sectional descriptive study was performed on 91 hemodialysis patients in Jahrom-Iran, 1400. The presence of anti-HGV antibodies in the serum of patients was evaluated by ELISA method. Demographic information, mean history of hemodialysis treatment and serum levels of liver enzymes were extracted from patients' records. The obtained data were statistically analyzed by SPSS-16 statistical software using descriptive statistics, T test and chi-square. 
Results: The prevalence of anti-HGV IgG and IgM were 5.46% and 0%, respectively. The prevalence of anti-HGV IgG was statistically significantly related to the history of blood transfusion and mean serum levels of ALT, AST, ALP (P<0.05), but there was no statistically significant relationship with the mean age and sex of patients (P>0.05).
Conclusions: The prevalence of hepatitis G virus in hemodialysis patients in Jahrom is equal to the average prevalence obtained in hemodialysis patients in other parts of the country. Further research is recommended to determine the role of this virus in causing hepatitis in hemodialysis patients.
Keywords: Hepatitis G virus (HGV), Sero-prevalence, Hemodialysis, Iran
Full-Text [PDF 723 kb]   (97 Downloads)    
Type of Study: Research | Subject: VirocShenaci
Received: 2021/11/26 | Revised: 2022/03/15 | Accepted: 2021/12/22
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

Research code: IR.JUMS.REC.1399.077
Ethics code: IR.JUMS.REC.1399.077


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shakeri M, Mojmeli A, rahmanian K, sotoodeh jahromi F, rahmanian A, sotoodeh jahromi A. Seroloprevalence of Hepatits G Virus (HGV) in Hemodialysis Patients Jahrom-Iran, 1400. jmj. 2021; 19 (4) :13-18
URL: http://jmj.jums.ac.ir/article-1-1674-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 19, Issue 4 (winter 2021) Back to browse issues page
فصلنامه دانشگاه علوم پزشکی جهرم Journal of Jahrom University of Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 29 queries by YEKTAWEB 4414